Security key
59102M104
- Security type / class
- Equity / COM
- Total 13F shares
- 10,727,379
- Share change
- -1,805,350
- Total reported value
- $38,723,693
- Reported price per share
- $3.61
- Number of holders
- 76
- Value change
- +$750,752
- Number of buys
- 51
- Number of sells
- 25
Security identity
Holder snapshot
Report period
Q4 2024
Institutions
76
Top holders
10
MGX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Metagenomi Therapeutics, Inc. SEC filings
Metagenomi Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 59102M104
Recent filing periods:
Ownership snapshot
Top shareholders of MGX - Metagenomi Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
BAYER HEALTHCARE LLC
13D/G signal
—
Evidence rows
50
Latest as of
30 Sep 2024
3/4/5
13F
Highest disclosed value: $11,666,871
Showing first 8 of 50 holder rows.
Open remaining rows
Rank 1 holder
BAYER HEALTHCARE LLC
3/4/5
- Ownership
- —
- Position
- $11.67M
Rank 2 holder
Novo Holdings A/S
3/4/5
13F
- Ownership
- —
- Position
- $5.01M
Rank 3 holder
Sebastian Bernales
3/4/5
- Ownership
- —
- Position
- $6.62M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAYER HEALTHCARE LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$11,666,871
4,050,997 shares
|
— | 13 Feb 2024 |
| Novo Holdings A/S |
3/4/5
13F
10%+ Owner · Company
|
—
class O/S missing
|
$5,008,824
1,739,175 shares
|
— | 09 Feb 2024 |
| Sebastian Bernales |
3/4/5
Director
|
—
mixed-class rows
|
$6,620,950
3,147,422 shares
mixed-class rows
|
— | 01 Apr 2024 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
—
class O/S missing
|
$2,832,369
1,305,239 shares
|
— | 30 Sep 2024 |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
Company
|
—
class O/S missing
|
$2,294,126
1,057,201 shares
|
— | 30 Sep 2024 |
| PFM Health Sciences, LP |
13F
Company
|
—
class O/S missing
|
$2,243,784
1,034,002 shares
|
— | 30 Sep 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
class O/S missing
|
$1,745,682
804,462 shares
|
— | 30 Sep 2024 |
| HHLR ADVISORS, LTD. |
13F
Company
|
—
class O/S missing
|
$1,687,757
777,768 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
76
Shares
10,727,379
Rows loaded
77
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
65
Q4 2024 holders
76
Holder diff
11
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend